Home › NDC Lookup › Ingredients › Dimenhydrinate › 63029-0902-01
Dramamine Orange Dimenhydrinate 50 mg Tablet, Chewable, 8-count — NDC 63029-0902-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Dramamine Orange Dimenhydrinate 50 mg Tablet, Chewable, 8-count — NDC 63029-902-01 (Billing 63029-0902-01)

by Medtech Products Inc. · 1 BLISTER PACK in 1 BOX / 8 TABLET, CHEWABLE in 1 BLISTER PACK

This is a package of 8 tablets of Dramamine Orange Dimenhydrinate 50 mg Tablet, Chewable from Medtech Products Inc., marketed since Jan 2012 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 63029-0902-01
🏷️ FDA NDC (as labeled) 63029-902-01 billing pads the product segment with a zero
This package
Contains8-count Pack sizes3 compare ↓
Main listing for product 63029-902 · Also comes in: 2 tablets 63029-902-02 4 tablets 63029-902-04
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 63029-902-01
Product NDC 63029-902
11-digit billing NDC 63029090201
NCPDP billing unit EA — each (per item)
RxCUI 309913, 602223
UNII JB937PER5C
Application # M009
SPL Set ID 76166156-bce1-492f-833e-6bbd07859c3f
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2012-01-15
Route ORAL
Dosage form TABLET, CHEWABLE
Substance DIMENHYDRINATE
Quick answers
  • RxCUI (RxNorm): 309913
Why two NDCs? The FDA registers this code as 63029-902-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 63029-0902-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Aminoalkyl ethers class.

Drug family (ATC) Aminoalkyl ethers
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Dimenhydrinate is used to prevent and treatmotion sickness. Dimenhydrinate is in a class of medications called antihistamines. It works by preventing problems with body balance.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It prevents and treats the nausea, vomiting and dizziness of motion sickness. You'll see it in products like Dramamine and Gravol, and as an injection used in medical settings.
  • To prevent motion sickness, take your first dose about 30 to 60 minutes before you start traveling. After that, follow the repeat timing and daily limit on your product's label. Ch...
  • Quite possibly. Drowsiness is the most common side effect. Be careful driving or using machinery, and skip alcohol.
  • Tell me what else you take. Sedatives, tranquilizers and other sedating drugs can add to drowsiness. It can also hide warning signs of ear damage from certain antibiotics.
📖 Read our full Dimenhydrinate guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 2 tablets 4 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
63029-0902-01 You're viewing this Main listing 1 BLISTER PACK in 1 BOX / 8 TABLET, CHEWABLE in 1 BLISTER PACK 2012-01-15 — Active
63029-0902-02 63029-902-02 2 TABLET, CHEWABLE in 1 POUCH 2012-01-15 — Active
63029-0902-04 63029-902-04 1 BLISTER PACK in 1 BOX / 4 TABLET, CHEWABLE in 1 BLISTER PACK 2013-03-30 Apr 30, 2028 Active

Pack size FAQ

What quantity is in this package?
This is a 8-count package — 1 blister pack in 1 box / 8 tablet, chewable in 1 blister pack.
How does this package differ from NDC 63029-0902-02?
Both are Dramamine Orange Dimenhydrinate 50 mg Tablet, Chewable — the drug itself is identical. This page's package is the 8-count one, while NDC 63029-0902-02 is the 2 tablets package.
What NDC number is used to bill for this package of Dramamine Orange Dimenhydrinate 50 mg Tablet, Chewable?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Gravol Chewables Motion Sickness Dimenhydrinate 50 mg 10237-0943-08 Church 8 tablets — — FDA listed —
Dramamine Chewable Dimenhydrinate 50 mg 50269-0525-00 JC 20 tablets — — FDA listed —
Dramamine Orange 50 mgthis 63029-0902-01 Medtech 8 tablets — — FDA listed —
Dramamine, TRAVEL BASIX 50 mg 66715-6409-02 Lil' 2 tablets — — FDA listed —
Dramamine 50 mg 66715-9809-01 Lil' 2 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2012
On the market since
Jan 2012
📍
2026
Currently FDA-listed
14 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color orange
ShapeRound
Size12 mm
ScoringScored — splits in 2
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII LMI26O6933
    Alumina is a white powder form of aluminum oxide. It's used as a filler to add bulk to tablets and capsules, and sometimes as a thickening or anti-caking agent in powdered formulations.
  • UNII XF417D3PSL
    Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
  • UNII Z0H242BBR1
    Aspartame is an artificial sweetener made from amino acids. It's added to medicines to improve taste, making bitter or unpleasant-tasting drugs easier to take.
  • UNII H77VEI93A8
    A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesanhydrous citric acid, aspartame, FD&C yellow #6 aluminum lake, flavors, magnesium stearate, maltodextrin, methacrylic acid copolymer, modified starch, sorbitol

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMedtech Products Inc.
FDA applicationM009 (OTC MONOGRAPH DRUG)
Labeler code63029
First marketedJan 2012
Product typeHuman Otc Drug
Portfolio57 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 15 words ▾

Use for prevention and treatment of these symptoms associated with motion sickness nausea vomiting dizziness

⏱️ Dosage and Administration 119 words ▾

Directions to prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity to prevent or treat motion sickness, see below: Adults and children 12 years and over take 1 to 2 tablets every 4-6 hours do not take more than 8 chewable tablets in 24 hours, or as directed by a doctor Children 6 to under 12 years give ½ to 1 tablet every 6-8 hours do not give more than 3 chewable tablets in 24 hours, or as directed by a doctor Children 2 to under 6 years give ½ tablet every 6-8 hours do not give more than 1 ½ chewable tablets in 24 hours, or as directed by a doctor

⚠️ Warnings 118 words ▾

Warnings Do not give to children under 2 years of age unless directed by a doctor Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma trouble urinating due to an enlarged prostate gland Ask a d octor or pharmacist before use if you are taking sedatives or tranquilizers When using this product marked drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery I f pregnant or breast-feeding, ask a doctor before use.

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

🧪 Active Ingredient 8 words ▾

Active ingredient (in each tablet) Dimenhydrinate 50 mg

🧪 Inactive Ingredients 21 words ▾

Inactive ingredients anhydrous citric acid, aspartame, FD&C yellow #6 aluminum lake, flavors, magnesium stearate, maltodextrin, methacrylic acid copolymer, modified starch, sorbitol

🎯 Purpose 2 words ▾

Purpose Antiemetic

📄 Do Not Use 15 words ▾

Do not give to children under 2 years of age unless directed by a doctor

📄 Ask a Doctor Before Use If 26 words ▾

Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma trouble urinating due to an enlarged prostate gland

📄 Ask a Doctor or Pharmacist Before Use If 15 words ▾

Ask a d octor or pharmacist before use if you are taking sedatives or tranquilizers

📄 When Using This Product 28 words ▾

When using this product marked drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery

🤰 If Pregnant or Breast-Feeding 10 words ▾

I f pregnant or breast-feeding, ask a doctor before use.

📄 Keep Out of Reach of Children 23 words ▾

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Other Information 38 words ▾

Other information Phenylketonurics: contains phenylalanine 0.84 mg per tablet store at room temperature 68-77ºF (20-25ºC) do not use if carton is opened or if blister is broken or torn see side panel for lot number and expiration date

📄 Questions or Comments 5 words ▾

Questions or comments? Call 1-800-382-7219

📄 Package Label / Principal Display Panel 124 words ▾

PRINCIPAL DISPLAY PANEL Dimenhydrinate Tablets/Antiemetic CHEWABLE FORMULA Dramamine ® MOTION SICKNESS RELIEF DUAL ACTION 1. TREATS SYMPTOMS ON THE SPOT 2. PREVENTS NAUSEA, DIZZINESS & VOMITING Convenient Chewable Tablets 8 ORANGE FLAVORED TABLETS (50 mg EACH) PRINCIPAL DISPLAY PANEL Dimenhydrinate Tablets/Antiemetic CHEWABLE FORMULA Dramamine® MOTION SICKNESS RELIEF DUAL ACTION 1. TREATS SYMPTOMS ON THE SPOT 2. PREVENTS NAUSEA, DIZZINESS & VOMITING Conven

PRINCIPAL DISPLAY PANEL Dimenhydrinate Tablets/Antiemetic CHEWABLE FORMULA Dramamine ® MOTION SICKNESS RELIEF DUAL ACTION 1. TREATS SYMPTOMS ON THE SPOT 2. PREVENTS NAUSEA, DIZZINESS & VOMITING Convenient Chewable Tablets 2 ORANGE FLAVORED TABLETS (50 mg EACH) PRINCIPAL DISPLAY PANEL Dimenhydrinate Tablets/Antiemetic CHEWABLE FORMULA Dramamine® MOTION SICKNESS RELIEF DUAL ACTION 1. TREATS SYMPTOMS ON THE SPOT 2. PREVENTS NAUSEA, DIZZINESS & VOMITING Conven

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2025 (Q1-Q4)

Medicare Part D (outpatient prescription) spending for Dimenhydrinate (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Dimenhydrinate. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Total Part D spend
$4K
Claims incl. refills
15
Beneficiaries
—
Spend / beneficiary
—
Spend / claim
$269.22
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Dramamine Orange (this brand).

Top reported reactions

Febrile Neutropenia811
Nausea670
Vomiting448
Fatigue423
Pyrexia416
Condition Aggravated355
Dyspnoea322

Age at onset

Neonate35
Infant56
Child194
Adolescent97
Adult671
Elderly316

Reporter sex

5,236 reports
Male · 42%
Female · 58%
Unknown · 0%

Serious outcomes

Hospitalization3,006
Life-threatening852
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 768 213
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Medtech Products Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 2 tablets (63029-0902-02), 4 tablets (63029-0902-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Medtech Products Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 63029-0901-01 · Medtech 63029-0903-01 · Medtech →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.